Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2005, Vol. 10 ›› Issue (1): 61-64.

Previous Articles     Next Articles

Experimental study on apoptosis of HepG2 cell induced by NS-398

ZHANG Ling-yi, ZHANG You-cheng, FU Sheng-jun, WANG Xiang, Ma Li   

  1. Department of Internal Medicine, the Second Hospital of LanzhouUniversity, Lanzhou 730030, Gansu, China
  • Received:2004-09-17 Revised:2004-12-20 Online:2005-01-26 Published:2020-11-19

Abstract: AIM: To study the effects of selective COX-2 inhibitor NS-398 on apoptosis of HepG2 cell line and to evaluate the modulation activity of Bcl-2 on the procession of HepG2 cell apoptosis.METHODS: HepG2 cells were cultured in RPMI1640 media and treated by NS-398 for 24, 48 and 72 hours.The apoptosis of HepG2 cells was observed by fluorescent microscopy, transmission electronmicroscopy and flow cytometric analysis.The expression of Bcl-2 in HepG2 cells during the apoptosis was measured by immunocellularchemical staining.RESULTS: NS-398 obviously induced some morphologic features of HepG2 cell apoptosis such as cellular nucleus shrinking, nucleus fragments, luniform chromatin agglutinating and chromatin fragmentation.Compared with the control group, the NS-398 group significantly decreased the expression of Bcl-2.CONCLUSION: COX-2 selective inhibitor NS-398 can significantly induce the apoptosis of hepG2 cells, and Bcl-2 may play an important role in modulating apoptosis induced by NS-398.

Key words: hepatic carcinoma, cyclooxygenase-2 inhibitor, NS-398, apoptosis, Bcl-2

CLC Number: